피페라진 시장 : 세계 산업 규모, 점유율, 동향, 기회, 예측 - 원료별(천연, 합성), 최종 용도별(의약품, 농약, 퍼스널케어 및 화장품, 기타), 지역별, 경쟁별(2020-2030년)
Piperazine Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Source (Natural, Synthetic), By End-use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others), By Region and Competition, 2020-2030F
상품코드:1668117
리서치사:TechSci Research
발행일:2025년 02월
페이지 정보:영문 187 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
한글목차
세계의 피페라진 시장 규모는 2024년에 34억 5,000만 달러로, 예측 기간 중 CAGR은 4.44%로 2030년에는 44억 9,000만 달러에 달할 것으로 예측됩니다.
피페라진 세계 시장은 의약품, 화학물질, 산업 공정 등 다양한 용도로 사용되어 꾸준한 성장세를 보이고 있습니다. 피페라진은 2개의 질소 원자를 포함하는 6원 복소환 구조를 가진 유기 화합물로 주로 다양한 의약품, 수지, 부식방지제의 합성 중간체로 사용됩니다. MDPI에 게재된 논문에 따르면 피페라진 유도체는 신약개발에서 세 번째로 널리 쓰이는 질소 헤테로고리로서 이마티닙(글리벡)과 실데나필(비아그라)에 이어 세 번째로 많이 쓰이는 질소 헤테로고리입니다. 실데나필(비아그라)을 포함한 여러 블록버스터 의약품의 중요한 구성 요소로 작용하고 있습니다. 제약 화학에서의 광범위한 응용에도 불구하고 피페라진의 구조적 다양성은 여전히 제한적이며, 피페라진을 포함한 의약품의 약 80%는 질소 위치에만 치환기를 가지고 있습니다.
시장 개요
예측 기간
2026-2030년
시장 규모 : 2024년
34억 5,000만 달러
시장 규모 : 2030년
44억 9,000만 달러
CAGR: 2025-2030년
4.44%
급성장 부문
합성
최대 시장
아시아태평양
피페라진 시장의 주요 촉진요인 중 하나는 제약 산업에서의 역할입니다. 구연산염 및 아디페이트와 같은 피페라진 유도체는 기생충에 의한 감염을 치료하는 구충제로 일반적으로 사용됩니다. 또한 피페라진은 정신과 약물 및 항염증약 합성에 중요한 중간체 역할을 합니다. 기생충 감염의 유병률 증가와 효과적인 의약품에 대한 수요 증가로 인해 피페라진 기반 의약품의 소비가 증가하고 있습니다. 또한 화학 및 폴리머 산업에서의 응용 또한 시장 성장을 가속하는 주요 요인으로 작용하고 있습니다. 피페라진은 코팅제, 접착제 및 복합재료에 필수적인 에폭시 수지의 제조에 사용됩니다. 또한 폴리우레탄 수지 및 폴리아미드 수지의 경화제 역할을 하여 기계적 특성을 향상시킵니다. 건설, 자동차, 항공우주 산업의 성장이 피페라진 기반 수지 및 폴리머 수요 증가에 기여하고 있습니다.
주요 시장 성장 촉진요인
의약품 수요 증가
주요 시장이 해결해야 할 과제
공급망 혼란과 지역 의존성
주요 시장 동향
탄소 포집 기술에 대한 수요 증가
목차
제1장 개요
제2장 조사 방법
제3장 개요
제4장 COVID-19가 세계의 피페라진 시장에 미치는 영향
제5장 세계의 피페라진 시장 전망
시장 규모·예측
금액·수량별
시장 점유율·예측
원료별(천연, 합성)
최종 용도별(의약품, 농약, 퍼스널케어 & 화장품, 기타)
지역별
기업별(2024)
시장 맵
제6장 북미의 피페라진 시장 전망
시장 규모·예측
시장 점유율·예측
북미 : 국가별 분석
멕시코
캐나다
제7장 유럽의 피페라진 시장 전망
시장 규모·예측
시장 점유율·예측
유럽 : 국가별 분석
독일
영국
이탈리아
스페인
제8장 아시아태평양의 피페라진 시장 전망
시장 규모·예측
시장 점유율·예측
아시아태평양 : 국가별 분석
인도
한국
일본
호주
제9장 남미의 피페라진 시장 전망
시장 규모·예측
시장 점유율·예측
남미 : 국가별 분석
아르헨티나
콜롬비아
제10장 중동 및 아프리카의 피페라진 시장 전망
시장 규모·예측
시장 점유율·예측
중동 및 아프리카 : 국가별 분석
사우디아라비아
아랍에미리트
제11장 시장 역학
촉진요인
과제
제12장 시장 동향과 발전
합병과 인수(있는 경우)
소스 출시(있는 경우)
최근 동향
제13장 세계의 피페라진 시장 : SWOT 분석
제14장 Porter's Five Forces 분석
업계내 경쟁
신규 참여의 가능성
공급업체의 힘
고객의 힘
대체품의 위협
제15장 경쟁 구도
BASF SE
Dow Inc.
Evonik Industries AG
Solvay S.A.
Albemarle Corporation
Shell plc
Huntsman Corporation
Akzo Nobel N.V.
Diamines and Chemicals Limited(DACL)
Shaoxing Xingxin New Materials Co., Ltd
제16장 전략적 제안
제17장 조사회사 소개·면책사항
KSA
영문 목차
영문목차
Global Piperazine Market was valued at USD 3.45 Billion in 2024 and is expected to reach USD 4.49 Billion by 2030 with a CAGR of 4.44% during the forecast period. The global piperazine market is witnessing steady growth due to its widespread applications in pharmaceuticals, chemicals, and industrial processes. Piperazine, an organic compound with a six-membered heterocyclic structure containing two nitrogen atoms, is primarily used as an intermediate in the synthesis of various drugs, resins, and corrosion inhibitors. The increasing demand for piperazine derivatives, especially in the pharmaceutical industry for the treatment of parasitic infections and neurological disorders, is driving market expansion. According to an article published in MDPI, piperazine is the third most prevalent nitrogen heterocycle in drug discovery and serves as a crucial component in several blockbuster pharmaceuticals, including Imatinib (marketed as Gleevec) and Sildenafil (sold as Viagra). Despite its extensive application in medicinal chemistry, the structural diversity of piperazines remains limited, with approximately 80% of piperazine-containing drugs featuring substituents exclusively at the nitrogen positions.
Market Overview
Forecast Period
2026-2030
Market Size 2024
USD 3.45 Billion
Market Size 2030
USD 4.49 Billion
CAGR 2025-2030
4.44%
Fastest Growing Segment
Synthetic
Largest Market
Asia Pacific
One of the key drivers of the piperazine market is its role in the pharmaceutical industry. Piperazine derivatives such as citrate and adipate salts are commonly used as anthelmintic drugs to treat infections caused by parasitic worms. Additionally, piperazine serves as a critical intermediate in the synthesis of psychiatric and anti-inflammatory drugs. The rising prevalence of parasitic infections, coupled with an increasing demand for effective medications, has boosted the consumption of piperazine-based pharmaceuticals. Another significant factor fuelling market growth is its application in the chemical and polymer industries. Piperazine is used in the production of epoxy resins, which are essential in coatings, adhesives, and composite materials. Also, it acts as a curing agent in polyurethane and polyamide resins, enhancing their mechanical properties. The growing construction, automotive, and aerospace industries are contributing to the rising demand for piperazine-based resins and polymers.
Key Market Drivers
Rising Demand in Pharmaceuticals
The global piperazine market is witnessing significant growth, primarily driven by its expanding application in the pharmaceutical industry. Piperazine, a versatile chemical compound, is widely used in the synthesis of various pharmaceutical drugs, particularly as an intermediate in producing anthelmintic medications, psychotropic drugs, and anti-tuberculosis treatments. The increasing prevalence of parasitic infections and neurological disorders, coupled with rising healthcare expenditures worldwide, is boosting the demand for piperazine-based pharmaceuticals. In March 2024, The Lancet Neurology published a major study revealing that in 2021, over 3 billion people globally had been living with a neurological condition. The World Health Organization (WHO) contributed to the analysis of the Global Burden of Disease, Injuries, and Risk Factor Study (GBD) 2021 data. The study confirmed that neurological conditions had become the leading cause of ill health and disability worldwide. Additionally, the total burden of disability, illness, and premature mortality-measured in disability-adjusted life years (DALYs)-had increased by 18% since 1990.
Key Market Challenges
Supply Chain Disruptions and Regional Dependencies
The global piperazine market is highly dependent on a few key manufacturing regions, such as China and India, which supply a substantial portion of the world's demand. Disruptions caused by trade restrictions, COVID-19-related lockdowns, or logistical bottlenecks can lead to supply shortages and price spikes. Additionally, reliance on a concentrated production base increases market vulnerability, making diversification a necessity but a challenging endeavor for companies seeking alternative suppliers.
Key Market Trends
Rising Demand for Carbon Capture Technologies
The increasing focus on reducing greenhouse gas emissions has led to significant advancements in carbon capture and storage (CCS) technologies, where piperazine-based solvents are playing a crucial role. As industries face stricter environmental regulations, CCS has emerged as a key strategy to curb CO2 emissions from power plants, industrial facilities, and oil refineries. Piperazine, known for its high reactivity with carbon dioxide, is being increasingly adopted in amine-based CO2 absorption processes to improve efficiency and reduce operational costs. According to the IEA, in 2023, the announced carbon capture capacity for 2030 increased by 35%, while the announced storage capacity grew by 70%. This expansion raised the total projected CO2 capture capacity for 2030 to approximately 435 million tonnes (Mt) per year, with the announced storage capacity reaching around 615 Mt of CO2 annually.
Traditionally, monoethanolamine (MEA) and diethanolamine (DEA) have been the primary solvents used for CO2 capture. However, these solvents often suffer from limitations such as low absorption capacity, high energy consumption for regeneration, and degradation over time. In contrast, piperazine has demonstrated superior reaction kinetics, higher CO2 absorption capacity, and improved thermal stability, making it an attractive alternative. It is commonly used in combination with other amines, such as methyldiethanolamine (MDEA) and MEA, to enhance the overall effectiveness of CO2 capture processes.
Key Market Players
BASF SE
Dow Inc.
Evonik Industries AG
Solvay S.A.
Albemarle Corporation
Shell plc
Huntsman Corporation
Akzo Nobel N.V.
Diamines and Chemicals Limited (DACL)
Shaoxing Xingxin New Materials Co., Ltd
Report Scope
In this report, the Global Piperazine Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Piperazine Market, By Source:
Natural
Synthetic
Piperazine Market, By Application:
Pharmaceutical
Agrochemicals
Personal Care & Cosmetics
Others
Piperazine Market, By Region:
North America
United States
Canada
Mexico
Europe
France
United Kingdom
Italy
Germany
Spain
Asia Pacific
China
India
Japan
Australia
South Korea
South America
Brazil
Argentina
Colombia
Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Piperazine Market.
Available Customizations:
Global Piperazine Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
Detailed analysis and profiling of additional market players (up to five).
Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, and Trends
4. Impact of COVID-19 on Global Piperazine Market
5. Global Piperazine Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value & Volume
5.2. Market Share & Forecast
5.2.1. By Source (Natural, Synthetic)
5.2.2. By End Use (Pharmaceutical, Agrochemicals, Personal Care & Cosmetics, Others)
5.2.3. By Region
5.2.4. By Company (2024)
5.3. Market Map
6. North America Piperazine Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value & Volume
6.2. Market Share & Forecast
6.2.1. By Source
6.2.2. By End Use
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Piperazine Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Source
6.3.1.2.2. By End Use
6.3.2. Mexico Piperazine Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Source
6.3.2.2.2. By End Use
6.3.3. Canada Piperazine Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Source
6.3.3.2.2. By End Use
7. Europe Piperazine Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value & Volume
7.2. Market Share & Forecast
7.2.1. By Source
7.2.2. By End Use
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. France Piperazine Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Source
7.3.1.2.2. By End Use
7.3.2. Germany Piperazine Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Source
7.3.2.2.2. By End Use
7.3.3. United Kingdom Piperazine Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Source
7.3.3.2.2. By End Use
7.3.4. Italy Piperazine Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Source
7.3.4.2.2. By End Use
7.3.5. Spain Piperazine Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Source
7.3.5.2.2. By End Use
8. Asia Pacific Piperazine Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value & Volume
8.2. Market Share & Forecast
8.2.1. By Source
8.2.2. By End Use
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Piperazine Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Source
8.3.1.2.2. By End Use
8.3.2. India Piperazine Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Source
8.3.2.2.2. By End Use
8.3.3. South Korea Piperazine Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Source
8.3.3.2.2. By End Use
8.3.4. Japan Piperazine Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Source
8.3.4.2.2. By End Use
8.3.5. Australia Piperazine Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Source
8.3.5.2.2. By End Use
9. South America Piperazine Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value & Volume
9.2. Market Share & Forecast
9.2.1. By Source
9.2.2. By End Use
9.2.3. By Country
9.3. South America: Country Analysis
9.3.1. Brazil Piperazine Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Source
9.3.1.2.2. By End Use
9.3.2. Argentina Piperazine Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Source
9.3.2.2.2. By End Use
9.3.3. Colombia Piperazine Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Source
9.3.3.2.2. By End Use
10. Middle East and Africa Piperazine Market Outlook
